Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
One Johnson & Johnson Plaza New Brunswick, NJ, 08933
The news was nonstop in 2020 and surprisingly, it wasn’t all related to the COVID-19 pandemic. There was plenty of other medtech news, including information about new technologies, new products, new companies — and a sneak preview of what to expect in 2021. The editors at Medical Design & Outsourcing decided to share the most-read…
COVID-19 dominated the news, but there was so much more going on in medtech. Let’s face it: These are soul-trying times, and no one is going to miss 2020. We’re leaving behind a year of tragedy and disaster — with the COVID-19 pandemic and its more than 1.6 million deaths (more than 300,000 in the…
Former Johnson & Johnson (NYSE:JNJ) executive Gina Bilotti is suing the company, alleging discrimination and verbal abuse from higher-up male executives. Nancy Erika Smith of Montclair, N.J.–based law firm Smith Mullin filed the lawsuit on behalf of Bilotti in the Superior Court of New Jersey in Essex County, according to a news release. According to the […]
Biotechnology traces its roots to the Neolithic era when early civilizations discovered how to ferment grains to prepare alcoholic brews and bread. It wasn’t until genetic engineering became mainstream in the mid-1970s, however, that biotechnology, as we know it today, was launched. The field continues to evolve today. The advent of new technology has revolutionized the market…
The heights of two weeks ago may not have been reached, but the medtech industry — despite a slight dip — performed well in the stock markets once again. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.99 (Nov. 20), marking a 1% downturn […]